PubMed Health⌕ Search

Biomedical subjects

K F Eckerman

Publications and source records attributed to K F Eckerman.

At least 19 recordsLinked to original sources

Charged particle equilibrium effects on the electron absorbed fraction in the extrathoracic airways.

Estimates of the dose to the extrathoracic airway (nasal vestibule) from inhaled beta-emitting radionuclides, obtained using the respiratory tract model presented in Publication 66 of the International Commission on Radiological Protection, frequently predict that the basal cells in this region are the most highly irradiated tissues of the body. The dose to the basal cells is averaged over a layer of tissue 10 microm thick located at a depth of 40 microm into the airway assuming that charged particle equilibrium exists. Since the target (basal cell layer) is very small and thin (10 cm(2) area and 10 microm thickness), charged particle equilibrium does not exist. In this work the effect on the absorbed fraction of the lack of charged particle equilibrium is investigated.

Beta Particles↗

A respiratory model for uranium aluminide based on occupational data.

As part of an epidemiological study, doses from intake of radionuclides were estimated for workers employed during a 52-year period at the Rocketdyne/Atomics International facility in California. The facility was involved in a variety of research programmes, including nuclear fuel fabrication, spent nuclear fuel decladding, and reactor operation and disassembly. Most of the documented intakes involved inhalation of enriched uranium (U), fission products, or plutonium (Pu). Highest doses were estimated for a group of workers exposed to airborne uranium aluminide (UAl(x)) during the fabrication of reactor fuel plates. Much of the exposure to UAl(x) occurred early in the fuel fabrication programme, before it was recognised that intake and lung retention were being underestimated from urinary data due to an unexpected delayed dissolution of the inhaled material. In workers who had been removed from exposure, the rate of urinary excretion of U increased for a few months, peaked, and then declined at a rate consistent with moderately soluble material. This pattern differs markedly from the monotonically decreasing absorption rates represented by the default absorption types in the Human Respiratory Tract Model (HRTM) of the International Commission on Radiological Protection (ICRP). This paper summarises the findings on the behaviour of UAl(x) in these workers and describes material-specific parameter values of the HRTM based on this information.

Air Pollutants, Radioactive↗

Adaptation of the ICRP publication 66 respiratory tract model to data on plutonium biokinetics for Mayak workers.

The biokinetics of inhaled plutonium were analyzed using compartment models representing their behavior within the respiratory tract, the gastrointestinal tract, and in systemic tissues. The processes of aerosol deposition, particle transport, absorption, and formation of a fixed deposit in the respiratory tract were formulated in the framework of the Human Respiratory Tract Model described in ICRP Publication 66. The values of parameters governing absorption and formation of the fixed deposit were established by fitting the model to the observations in 530 autopsy cases. The influence of smoking on mechanical clearance of deposited plutonium activity was considered. The dependence of absorption on the aerosol transportability, as estimated by in vitro methods (dialysis), was demonstrated. The results of this study were compared to those obtained from an earlier model of plutonium behavior in the respiratory tract, which was based on the same set of autopsy data. That model did not address the early phases of respiratory clearance and hence underestimated the committed lung dose by about 25% for plutonium oxides. Little difference in lung dose was found for nitrate forms.

Absorption↗

Mayak worker study: an improved biokinetic model for reconstructing doses from internally deposited plutonium.

The plutonium production facility known as the Mayak Production Association was put into operation in June 1948. A high incidence of cancer in the Mayak workers has been related to the level of exposure to plutonium, but uncertainties in tissue doses have hampered development of dose-risk relationships. As part of an effort to improve dose estimates for these workers, the systemic biokinetic model for plutonium currently recommended by the International Commission on Radiological Protection (ICRP) has been modified to reflect recently developed data and facilitate interpretation of case-specific information. This paper describes the proposed model and discusses its implications for dose reconstruction for the Mayak workers.

Bone and Bones↗

Electron absorbed fractions based on a new model of the anterior nasal passage.

In a previous work we reported that the fraction of the electron energy absorbed in the basal cell layer of the anterior nasal passages was not very sensitive to changes in the surface area or radius of the cylindrical model adopted in Publication 66 of the International Commission on Radiological Protection. These absorbed fraction data are used in calculation of the dose to a 10-microm-thick basal cell layer located at a depth of 40 microm in the epithelial cell layer of the extrathoracic (ET1) region. However, these data may only be applicable to the assumed cylindrical geometry and may not be valid for more realistic ET1 geometries. The nose differs in size and shape from one person to another, its shape is not cylindrical but closer to a truncated elliptical cone, and in most humans the nostrils are elliptical in shape. We propose herein a more realistic geometry model, the frustum of a cone, for the anterior nose region (ET1) as an alternative to the cylinder model provided in ICRP 66. The results of absorbed fraction calculations using MCNP4B with the new model are reported. These absorbed fractions are compared to the values previously obtained using the MCNP4B code and a cylindrical model (10 cm2 surface area). We also investigate the effects of changing the size of the truncated cone to represent variations due to sex and age.

Administration, Inhalation↗

Dose coefficients for the embryo and fetus following intakes of radionuclides by the mother.

The International Commission on Radiological Protection has recently issued Publication 88, giving dose coefficients for the embryo, fetus and newborn child from intakes of selected radionuclides of 31 elements by the mother, either before or during pregnancy. The biokinetic models used for calculating these doses were based upon the available human data and the results of animal experiments. This paper summarises the approach used for the development of biokinetic and dosimetric models. It also compares the estimates of dose received by the offspring with those received by the reference adult. The main findings are that, in general, doses to the offspring are similar to or lower than those to the reference adult. For a few radionuclides, however, the dose to the offspring can exceed that to the adult. The reasons for these variations in comparative doses are examined.

Administration, Inhalation↗

Dosimetry of radioiodine for embryo and fetus.

This paper discusses the biokinetic and dosimetric models adopted in ICRP Publication 88 for the evaluation of fetal doses resulting from maternal intakes of radioiodine. The biokinetic model is used to simulate the behaviour of iodine in both the mother and the fetus. Such simulations provide the basis for the estimation of the dose to the embryo and determine the distribution of maternal iodine at the beginning of the fetal period. The model considers iodine to accumulate in the fetal thyroid from the 11th week. The dose to the fetus delivered following birth is evaluated with the biokinetic and dosimetric models described in ICRP Publication 67. Although a substantial fraction of the emitted energy of electrons and photons is less than 10 keV, conventionally assumed to be non-penetrating radiation, these emissions can escape the small fetal thyroid. Absorbed fractions for both self-dose and crossfire were evaluated for the requirements of radioiodine dosimetry in ICRP Publication 88.

Administration, Oral↗

Some aspects of the fetal doses given in ICRP Publication 88.

The International Commission on Radiological Protection (ICRP) has recently published dose coefficients (dose per unit intake, Sv Bq(-1)) for the offspring of women exposed to radionuclides during or before pregnancy. These dose estimates include in utero doses to the embryo and fetus and doses delivered postnatally to the newborn child from radionuclides retained at birth. This paper considers the effect on doses of the time of radionuclide intake and examines the proportion of dose delivered in utero and postnatally for different radionuclides. Methods used to calculate doses to the fetal skeleton are compared. For many radionuclides, doses are greatest for intakes early in pregnancy but important exceptions, for which doses are greatest for intakes later in pregnancy, are iodine isotopes and isotopes of the alkaline earth elements, including strontium. While radionuclides such as 131I deliver dose largely in utero, even for intakes late in pregnancy, others such as 239Pu deliver dose largely postnatally, even for intakes early during pregnancy. For alpha emitters deposited in the skeleton, the assumption made is of uniform distribution of the radionuclide and of target cells for leukaemia and bone cancer in utero; that is, the developing bone structure is not considered. However, for beta emitters, the bone structure was considered. Both approaches can be regarded as reasonably conservative, given uncertainties in particular in the location of the target cells and the rapid growth and remodelling of the skeleton at this stage of development.

Aging↗

An analysis of a puncture wound case with medical intervention.

A worker noted a small wound to his thumb when leaving a work site that was undergoing decontamination because of past operations with plutonium (Pu) and americium (Am). Direct surveys of the wound site confirmed the presence of contamination. The chelating agent Ca-DTPA was administered via a nebuliser within an hour after discovery of the wound. External measurements were made of the wound site and wound dressings; 24-h urinary excretion data were collected periodically and the Pu and Am urine content was determined. Zn-DTPA was administered on three occasions. The ICRP Pu systemic model was modified to consider the enhanced urinary excretion following administration of the chelating agents. The analysis indicated that the wound resulted in an initial deposition of 400 Bq 238Pu, 2240 Bq (239/240)Pu and 1060 Bq 241Am. About 70% of the initial wound activity was removed by surgical procedures and less than 1% of the wound activity was removed by chelation therapy. This paper compares the observed urinary excretion data with that indicated by a simulation of the kinetics of the transfer from the wound site and the kinetics of the chelating agent and Pu.

Administration, Inhalation↗

Development and assessment of a new radioactive decay database used for dosimetry calculation.

The present paper discusses the technical issues and a scheme for their resolution before undertaking the development of a new radioactive decay database to succeed ICRP38. The scheme consists of the following procedures. (1) The consistency of nuclear structure data files used as input to the computer code EDISTR is established by referring to the latest nuclear parameters and by comparing the computed energies of emitted radiations with total decay energy. (2) A method for calculating detailed spectra of X rays and Auger electrons is incorported into EDISTR to enhance the treatment of atomic relaxation processes initiated by electron vacancies from internal conversion and electron capture. (3) Quality assurance of the compiled data is undertaken by comparisons with experimental data and other decay databases prepared from different computer codes and libraries. JAERI and ORNL are cooperating to implement the scheme in order to assemble a comprehensive radioactive decay database including over 1000 nuclides.

Database Management Systems↗

Dose coefficients for the embryo and foetus following intakes of radionuclides by the mother.

Committee 2 of the International Commission on Radiological Protection (ICRP) has the responsibility for calculating radiation doses from intakes of radionuclides for all age groups in the population. Publication 88 of the ICRP, which has recently been published, describes the development of models used for calculating radiation doses to the embryo and foetus following intakes of radionuclides by the mother. It also gives radiation doses to the offspring for intakes of radionuclides by the mother either before or during pregnancy. The approaches used in the development of the biokinetic and dosimetric models are summarised here together with a comparison of the doses to the offspring with those to the reference adult.

Adult↗

Evolution and status of bone and marrow dose models.

Investigations at the University of Leeds under the direction of F.W. Spiers in the early 1960s through the late 1970s established the first comprehensive assessment of marrow dose conversion factors (DCFs) for beta-emitting radionuclides within the volume or on the surface of trabecular bone. These DCFs were subsequently used in deriving radionuclide S values for skeletal tissues published in MIRD Pamphlet No. 11. Eckerman re-evaluated this work and extended the methods of Spiers to radionuclides within the marrow to provide DCFs for fifteen skeletal regions in computational models representing individuals of six different ages. These results were used in the MIRDOSE3 software. Bouchet et al. used updated information on regional bone and marrow masses, as well as 3D electron transport techniques, to derive radionuclide S values in skeletal regions of the adult. Although these two efforts are similar in most regards, the models differ in three respects in: (1) the definition of the red marrow region, (2) the definition of a surface source of activity, and (3) the assumption applied in transporting electrons through the trabecular endosteum. In this study, a review of chord-based skeletal models is given, followed by a description of the differences in the Eckerman and Bouchet et al. transport models. Finally, new data from NMR microscopy and radiation transport in trabecular bone is applied to address item (1) above. Dose conversion factors from MIRD 11, the Eckerman model, the Bouchet et al. model, and a revised model are compared for several radionuclides important to internal emitter therapy.

Animals↗

Self-absorption effects on electron absorbed fraction in the anterior nose.

The electron absorbed fraction in the anterior nose is estimated in the International Commission on Radiological Protection Publication 66 using the EGS4 Code and a cylinder model. The electrons are assumed to come from point sources lining the inner surface of the nose. Although the radioactive source particles are carried in dust, self-absorption in the dust is ignored. Consequently, the absorbed fractions published in ICRP 66 cannot represent the correct energy deposition in the basal cell region. In this work we estimate the energy lost by the emitted electrons inside spherical dust particles, which vary in diameter from 1 micron to 100 microns. The absorbed fractions in the basal cell layer are then estimated using the modified electron energy spectrum. To illustrate these effects, modified absorbed fractions for a dust particle radius of 20 microns are compared to the absorbed fractions presented in ICRP 66. Significant differences are noted.

Absorption↗

Absorbed fraction sensitivity to changes in size of the ICRP nose model.

The Human Respiratory Tract Model of ICRP Publication 66 is used for calculations of dose in the extrathorathic (ET1) airways. Scaling for age and body size is included in determining the mass of the target tissue (basal cells) in ET1 but is not included in deriving the absorbed fraction for particulate radiation. For dose calculations, it has been assumed that all absorbed fractions for particulate radiation published in ICRP Publication 66 are independent of age and body size. Therefore, these absorbed fractions are applied to calculate specific effective energy values not only for the Reference Worker but also for non-adults with noses of different sizes. In this note changes to the size of the cylinder model of the anterior nose in ICRP 66 are made by varying the surface area, the cylinder radius, and the thickness of tissue beyond the target region (basal cell). The energy deposition (absorbed fractions) in the target region (basal cells) is calculated using the MCNP4B (Monte Carlo) code to study the effects of these changes on the predicted absorbed fractions within the cylinder model.

Electrons↗

A systemic biokinetic model for polonium.

Although the biokinetics of polonium has been studied extensively, interpretation of the data is complicated by potential differences with species and route of exposure and the questionable reliability of much of the reported excretion data for man. A study was undertaken to identify the data that are most likely to represent the typical behavior of polonium and apply those data to construct an improved, physiologically realistic systemic biokinetic model for polonium in man. Such a model is needed for interpretation of urinary excretion data for workers exposed to 210Po and reconstruction of the radiation doses received by those workers. This paper reviews the database on the biokinetics of polonium and describes a new systemic biokinetic model for polonium in man.

Air Pollutants, Occupational↗

Estimation of electron absorbed fractions in the extrathoracic airways.

Dose calculations using the respiratory tract model presented in Publication 66 of the International Commission on Radiological Protection (ICRP) frequently predict that the basal cells of the anterior portion of the nose, the extrathoracic region ET1 of the model, are the most highly irradiated tissue of the body. The dose to the basal cells is averaged over a layer of tissue 10 microm thick located at a depth of 40 microm into the airway. Reported here are the results of a series of absorbed fraction calculations undertaken to compare with values tabulated in ICRP Publication 66. The Monte Carlo code MCNP4B and the geometric model of the ET1 region specified in Publication 66 were used in the calculations. Although some calculated differences are evident between the two sets of absorbed fractions, typically less than 20%, the calculations confirm that the electron absorbed fractions tabulated in Publication 66 are not responsible for the high estimates of the ET1 dose.

Electrons↗

Proposed revision of the ICRP model for inhaled mercury vapor.

A critical review of the literature on the biokinetics of inhaled mercury vapor was performed as part of an accident analysis for the Spallation Neutron Source to be built at Oak Ridge National Laboratory. It was concluded that current models for inhaled mercury vapor do not accurately describe the distribution or residence time of mercury deposited in the respiratory tract. This paper proposes a model that is more consistent with collective information on the fate of inhaled mercury vapor in laboratory animals and human subjects. Compared with the model currently recommended by the International Commission on Radiological Protection (ICRP), the proposed model predicts lower deposition in the bronchi and bronchioles, greater deposition in the alveolar-interstitial region, and a different pattern of absorption to blood. The proposed model yields substantially reduced estimates of lung dose and effective dose for most radioisotopes of mercury inhaled as mercury vapor.

Animals↗

Contribution to red marrow absorbed dose from total body activity: a correction to the MIRD method.

UNLABELLED: The contribution to red marrow absorbed dose from beta-emitting radionuclides distributed uniformly in the total body can be overestimated using either MIRD 11 or MIRDOSE3. The S value assigned to the red marrow target region from activity distributed in the remainder of the body is of particular concern. The assumption that the specific absorbed fraction for total body irradiating red marrow and other skeletal tissues is the inverse of the total-body mass can result in an inappropriate remainder-of-body contribution to marrow dose. We evaluated differences in the calculation of marrow dose using MIRD 11 and MIRDOSE3 formulations and developed methods to correct the results from either to remove inappropriate contributions. When bone takes up significantly less activity than is predicted from an apportionment of remainder-tissue activity based on mass, the standard remainder-of-body correction may substantially overestimate the electron component of the S value from remainder tissues to red marrow using either MIRD 11 or MIRDOSE3. If bone takes up activity, this contribution is negligible using MIRD 11 S values but remains with MIRDOSE3 S values. This overestimate can be significant, particularly when the residence time of activity in the remainder of the body is much higher than in the red marrow and a different correction is needed. As the ratio of the remainder of body to marrow residence time is lowered, the overestimate becomes less significant. CONCLUSION: In this article, we show the magnitude of this overestimate (which is most important for nuclides with large "nonpenetrating" emission components and for pharmaceuticals that have a large ratio of remainder of body to marrow residence times), show the appropriate corrections to be made in each case, and propose a new method for calculating marrow dose contributions that will avoid this complication in future applications. Because all models give approximate doses for real patients, with uncertainties within those involved in these corrections, we do not suggest that changes be made to existing marrow dose estimates. We suggest only that future calculations be as accurate as possible.

Beta Particles↗